Liminatus Pharma, Inc. Class A Common Stock LIMN Q1 2026 Annual earnings
Reported May 15, 2026 · Before market open
Next report
Date not yet announcedVersus estimates
Diluted EPS
Ask the moment Liminatus Pharma, Inc. Class A Common Stock reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Liminatus Pharma, Inc. Class A Common Stock report Q1 2026 earnings?
- Liminatus Pharma, Inc. Class A Common Stock (LIMN) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Liminatus Pharma, Inc. Class A Common Stock's Q1 2026 revenue and EPS?
- Liminatus Pharma, Inc. Class A Common Stock reported diluted EPS of $-0.03 for Q1 2026.
- Where can I find Liminatus Pharma, Inc. Class A Common Stock's Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001104659-26-037933) directly on SEC EDGAR. The filing index links above go to sec.gov.